🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.

Investigational Treatment Acquiring Traction Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles directly for supplier links, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where communities with numerous of members share comparison photos, administration instructions and claims of next-day British shipping. Sellers market the drug there before redirecting customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Voice Worries

However, physicians and pharmacists have cautions that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals injecting substances of unknown origin.

Some professionals said the demand for retatrutide could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.

Several influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate medicines, advertising, and customer laws, potentially leading to penalties, legal action or prison.

Service Response and Content Elimination

According to the social media company, the platform has taken down violative material and prohibited related hashtags and search suggestions. The organization said it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.

Digital Trading Operations

Research also found communities with up to 9,000 members selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, filled with photos of weight loss, glowing reviews and step-by-step instructions for preparing or injecting at home.

After minutes of joining one community, a seller posted contact information, where most purchases take place. The seller sent an instruction manual and guaranteed delivery within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, health issues or previous experience.

Product Information and Pricing

Within these groups, messages show dark colored parcels with postal service labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A representative for Telegram said it actively monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting materials they can’t verify. Even if the research behind this drug is valid, these digital products may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her team has already seen patients harmed by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose users to possibly serious health risks”.